| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 322.20M | 306.10M | 295.70M | 285.10M | 269.40M | 268.80M |
| Gross Profit | 146.20M | 143.50M | 147.80M | 134.60M | 121.00M | 130.50M |
| EBITDA | 32.80M | 28.20M | 19.10M | 19.70M | 15.60M | 23.10M |
| Net Income | 15.30M | 12.90M | 5.50M | 11.80M | 9.20M | 14.30M |
Balance Sheet | ||||||
| Total Assets | 185.80M | 168.40M | 158.50M | 99.00M | 94.50M | 80.70M |
| Cash, Cash Equivalents and Short-Term Investments | 21.20M | 17.70M | 11.20M | 46.40M | 45.50M | 32.70M |
| Total Debt | 52.60M | 51.10M | 46.10M | 4.80M | 5.00M | 5.80M |
| Total Liabilities | 122.30M | 107.80M | 106.20M | 50.20M | 50.50M | 49.90M |
| Stockholders Equity | 63.50M | 60.60M | 52.30M | 48.80M | 44.00M | 30.80M |
Cash Flow | ||||||
| Free Cash Flow | 27.90M | 20.60M | -7.40M | 12.70M | 14.00M | 21.20M |
| Operating Cash Flow | 28.80M | 22.00M | 17.40M | 17.70M | 16.90M | 24.40M |
| Investing Cash Flow | -7.10M | -5.40M | -43.90M | -5.00M | -2.90M | 2.70M |
| Financing Cash Flow | -11.40M | -10.10M | -8.70M | -11.80M | -1.20M | -4.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £4.20B | 15.71 | 23.58% | 2.57% | 4.13% | 8.25% | |
70 Outperform | £269.30M | 16.93 | 24.66% | 2.49% | 7.34% | 169.28% | |
66 Neutral | £4.73B | 19.74 | 3.91% | 3.99% | 1.26% | 40.14% | |
64 Neutral | £71.20M | 13.16 | 89.58% | 6.86% | 8.67% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £381.72M | 10.42 | 29.52% | 3.83% | 6.33% | 125.67% | |
43 Neutral | £23.28M | -0.28 | -61.90% | ― | -15.92% | -227.33% |